New York, May 10, 2018: The analysts forecast global Vagus Nerve Stimulation Market for the mining sector to grow at a CAGR of 10% during the period 2016-2022.
According to the market research engine analyst, the global VNS market is anticipated to grow at a steady rate and can post a CAGR of close to 100 pc during the forecast period. The availability of favorable reimbursement and insurance approval policies will drive the growth prospects for the global VNS market until the end of 2021. The availability of favorable reimbursement policies encourages a large range of specialists to utilize VNS devices and increase the investments made in the development of new technologies for the treatment of epilepsy and other cardiac indications. According to the market research analysis, many health systems are increasingly taking efforts to negotiate better prices on implantable medical devices to enforce reimbursement policies by encouraging provide chain system to drive down the prices of neuromodulation and VNS devices.
The scope of the report includes a detailed study of global and regional markets on Vagus Nerve Stimulation Market with the reasons given for variations in the growth of the industry in certain regions.
You Can Browse Full Report: https://www.marketresearchengine.com/vagus-nerve-stimulation-market
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include LivaNova, Enteromedics, ElectroCorea and Cerbomed. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The major driving factors of Vagus Nerve Stimulation Market are as follows:
- Increasing prevalence of neurological disorders
- Favorable reimbursement and insurance approval policies
- Rising demand for external VNS devices
The challenges factors of Vagus Nerve Stimulation Market are as follows:
- Stringent regulatory approvals and high cost of devices
- Complications related to VNS
- High maintenance and low battery lifetime
The trends factors of Vagus Nerve Stimulation Market are as follows:
- Shift of surgeons focus toward minimally invasive VNS procedures
- Next-generation therapies for nervous system disorders
- Application of VNS in other indications
This report provides:
This report covers the present scenario and the growth prospects of the global Vagus Nerve Stimulation Market for 2016-2022. To calculate the market size, the report considers the revenue generated from the sales of robotic pharmacy prescription systems.
The Vagus Nerve Stimulation Market has been segmented as below:
By Product Analysis:
- Implantable VNS devices
- External VNS devices
By Regional Analysis:
- North America
- Rest of World
You Can Buy Full Report: https://www.marketresearchengine.com/vagus-nerve-stimulation-market
Table of Contents
Chapter: 1 INTRODUCTION
Chapter: 2 EXECUTIVE SUMMARY
Chapter: 3 MARKET OVERVIEW
Chapter: 4 GLOBAL VAGUS NERVE STIMULATION (VNS) MARKET, BY PRODUCT
Chapter: 5 GLOBAL VAGUS NERVE STIMULATION (VNS) MARKET, BY APPLICATION
5.1.1. Market size and forecast
5.2.1. Market size and forecast
5.3.1. Market size and forecast
5.4.1. Market size and forecast
Chapter: 6 GLOBAL VAGUS NERVE STIMULATION (VNS) MARKET, BY END USER
Chapter: 7 GLOBAL VAGUS NERVE STIMULATION (VNS) MARKET, BY BIOMATERIAL
Chapter: 8 GLOBAL VAGUS NERVE STIMULATION (VNS) MARKET, BY REGION
Chapter: 9 COMPANY PROFILES
9.1. MEDTRONIC PLC
9.2. ELECTROCORE LLC
9.3. LIVANOVA PLC
9.4. BOSTON SCIENTIFIC CORPORATION
9.5. ALEVA NEUROTHERAPEUTICS SA
9.6. BIOCONTROL MEDICAL
9.7. BIONESS INC.
9.8. ENTEROMEDICS INC.
9.9. NEVRO CORPORATION
9.10. NEUROPACE INC.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States